Procurement Summary
Country : Germany
Summary : Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Adalimumab (atc Code: L04ab04)
Deadline : 27 Aug 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 45763084
Document Ref. No. : 431501-2020
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : AOK - THE HEALTH FUND FOR LOWER SAXONY
Address: Hildesheimer Str. 273
Town: Hanover
NUTS code: DE9 - NIEDERSACHSEN
Postal Code: 30519
Contact Point: Pharmaceutical Management Division
Germany
Email :rabattvertraege@nds.aok.de
URL :www.aok.de
Tender Details
Document Type: Contract notice
Title: Conclusion of a non-exclusive discount agreement according to Section 130a (8) SGB V for medicinal products with the active ingredient adalimumab (ATC code: L04AB04)
Reference Number: 2020 / S 179-431501
Contract Type: Supplies
Description: Conclusion of a non-exclusive discount agreement in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient adalimumab (ATC code: L04AB04) within the period from November 1, 2020 to October 31, 2022 with the option of concluding a contract at any time during the term (" open-house model ").
The contractual partners can be viewed at: https://www.aok-gesundheitpartner.de/nds/arzneimittel/rabatt/index_03504.html?bl=nds
33600000 - Pharmaceutical products
Authority Type: Body governed by public law
Type of Procedure: Open procedure
Regulation: European Union
Bid Type: Submission for all lots
Doc Title: Pharmaceutical products
Dispatch Date: 2020-09-10
Publish Date: 2020-09-15
Submission Date: 2022-08-27
Documents
Tender Notice